Detalles de la búsqueda
1.
Advance Care Planning (ACP) in Medicare Beneficiaries with Heart Failure.
J Gen Intern Med
; 2024 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-38769259
2.
How Ohio public library systems respond to opioid-related substance use: a descriptive analysis of survey results.
BMC Public Health
; 24(1): 1336, 2024 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38760681
3.
Retrospective cohort study of scalp cooling in breast cancer patients.
Support Care Cancer
; 31(2): 118, 2023 Jan 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36645520
4.
Controlling the false-discovery rate when identifying the subgroup benefiting from treatment.
Clin Trials
; 20(4): 394-404, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37122134
5.
The Evolution of Primary Care Telehealth Disparities During COVID-19: Retrospective Cohort Study.
J Med Internet Res
; 25: e43965, 2023 05 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37146176
6.
Extraction of mobile charge carrier photogeneration yield spectrum of ultrathin-film metal oxide photoanodes for solar water splitting.
Nat Mater
; 20(6): 833-840, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33875852
7.
Long-Term Pooled Safety Analysis of Palbociclib in Combination with Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Updated Analysis with up to 5 Years of Follow-Up.
Oncologist
; 26(5): e749-e755, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33486783
8.
Evaluation of the Association of Polymorphisms With Palbociclib-Induced Neutropenia: Pharmacogenetic Analysis of PALOMA-2/-3.
Oncologist
; 26(7): e1143-e1155, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33955129
9.
Hematologic adverse events following palbociclib dose reduction in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: pooled analysis from randomized phase 2 and 3 studies.
Breast Cancer Res
; 22(1): 27, 2020 03 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32164785
10.
Palbociclib with Letrozole in Postmenopausal Women with ER+/HER2- Advanced Breast Cancer: Hematologic Safety Analysis of the Randomized PALOMA-2 Trial.
Oncologist
; 24(12): 1514-1525, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31217344
11.
Multiplicity-adjusted semiparametric benefiting subgroup identification in clinical trials.
Clin Trials
; 15(1): 75-86, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29035083
12.
Author Correction: Extraction of mobile charge carrier photogeneration yield spectrum of ultrathin-film metal oxide photoanodes for solar water splitting.
Nat Mater
; 20(11): 1579, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34504312
13.
Efficacy and safety of palbociclib in combination with letrozole as first-line treatment of ER-positive, HER2-negative, advanced breast cancer: expanded analyses of subgroups from the randomized pivotal trial PALOMA-1/TRIO-18.
Breast Cancer Res
; 18(1): 67, 2016 06 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-27349747
14.
Palbociclib in Combination With Fulvestrant in Women With Hormone Receptor-Positive/HER2-Negative Advanced Metastatic Breast Cancer: Detailed Safety Analysis From a Multicenter, Randomized, Placebo-Controlled, Phase III Study (PALOMA-3).
Oncologist
; 21(10): 1165-1175, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27368881
15.
A Bayesian credible subgroups approach to identifying patient subgroups with positive treatment effects.
Biometrics
; 72(4): 1026-1036, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27159131
16.
Reliability and initial validation of the ulcerative colitis endoscopic index of severity.
Gastroenterology
; 145(5): 987-95, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23891974
17.
Clinical dose rationale of tislelizumab in patients with solid or hematological advanced tumors.
Clin Transl Sci
; 17(3): e13769, 2024 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38515348
18.
A feasibility randomized controlled trial of an mHealth app vs booklets for patient-facing guidelines in adults with SCD.
Blood Adv
; 7(20): 6184-6190, 2023 Oct 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37595029
19.
Genetic counseling and testing for females at elevated risk for breast cancer: Protocol for the randomized controlled trial of the Know Your Risk intervention.
Contemp Clin Trials
; 133: 107323, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37661005
20.
Biomechanical effect of neurologic dance training (NDT) for breast cancer survivors with chemotherapy-induced neuropathy: study protocol for a randomized controlled trial and preliminary baseline data.
Trials
; 24(1): 564, 2023 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37658464